These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2115349)
1. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Buhaug H; Skjeldestad FE; Halvorsen LE; Dalen A Br J Gen Pract; 1990 Apr; 40(333):142-5. PubMed ID: 2115349 [TBL] [Abstract][Full Text] [Related]
2. [Asymptomatic genital infection by Chlamydia trachomatis in women. A cost analysis of control check-ups]. Schiøtz HA; Csángó PA Tidsskr Nor Laegeforen; 1991 Mar; 111(7):848-50. PubMed ID: 1902332 [TBL] [Abstract][Full Text] [Related]
3. [Which women should be tested for Chlamydia trachomatis in general practice?]. Halvorsen LE; Skjeldestad FE; Nordbø SA; Løge I Tidsskr Nor Laegeforen; 1992 Jun; 112(16):2080-1. PubMed ID: 1523627 [TBL] [Abstract][Full Text] [Related]
4. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses. van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651 [TBL] [Abstract][Full Text] [Related]
5. [Chlamydia trachomatis infection in men and its association with gynecologic alterations in their sexual partners]. Guerra-Infante FM; Tapia-Yáñez JR; López-Hurtado M; Flores-Medina S; Díaz-García FJ Rev Invest Clin; 2005; 57(3):406-14. PubMed ID: 16187700 [TBL] [Abstract][Full Text] [Related]
6. Trends of reported chlamydia infections and related complications in New Zealand, 1998-2008. Morgan J; Colonne C; Bell A Sex Health; 2011 Sep; 8(3):412-8. PubMed ID: 21851784 [TBL] [Abstract][Full Text] [Related]
7. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]. Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Land JA; Van Bergen JE; Morré SA; Postma MJ Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674 [TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of testing for chlamydial infections in asymptomatic women. Buhaug H; Skjeldestad FE; Backe B; Dalen A Med Care; 1989 Aug; 27(8):833-41. PubMed ID: 2502694 [TBL] [Abstract][Full Text] [Related]
10. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137 [TBL] [Abstract][Full Text] [Related]
11. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination. Davies HD; Wang EE CMAJ; 1996 Jun; 154(11):1631-44. PubMed ID: 8646651 [TBL] [Abstract][Full Text] [Related]
13. Assessing the number of genital chlamydial infections in the United States. Judson FN J Reprod Med; 1985 Mar; 30(3 Suppl):269-72. PubMed ID: 4020783 [TBL] [Abstract][Full Text] [Related]
14. Chlamydia trachomatis genital infections--United States, 1995. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(9):193-8. PubMed ID: 9072679 [TBL] [Abstract][Full Text] [Related]
15. The impact of a comprehensive chlamydia prevention program in Wisconsin. Hillis SD; Nakashima A; Amsterdam L; Pfister J; Vaughn M; Addiss D; Marchbanks PA; Owens LM; Davis JP Fam Plann Perspect; 1995; 27(3):108-11. PubMed ID: 7672100 [TBL] [Abstract][Full Text] [Related]
16. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Bender N; Herrmann B; Andersen B; Hocking JS; van Bergen J; Morgan J; van den Broek IV; Zwahlen M; Low N Sex Transm Infect; 2011 Dec; 87(7):601-8. PubMed ID: 22028428 [TBL] [Abstract][Full Text] [Related]
17. Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Andersen B; van Valkengoed I; Sokolowski I; Møller JK; Østergaard L; Olesen F Sex Transm Infect; 2011 Mar; 87(2):156-61. PubMed ID: 21097811 [TBL] [Abstract][Full Text] [Related]
18. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. Rekart ML; Gilbert M; Meza R; Kim PH; Chang M; Money DM; Brunham RC J Infect Dis; 2013 Jan; 207(1):30-8. PubMed ID: 23100568 [TBL] [Abstract][Full Text] [Related]
19. Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population. Scholes D; Satterwhite CL; Yu O; Fine D; Weinstock H; Berman S Sex Transm Dis; 2012 Feb; 39(2):81-8. PubMed ID: 22249294 [TBL] [Abstract][Full Text] [Related]
20. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women. Blandford JM; Gift TL Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]